Newsletter | April 28, 2022

04.28.22 -- Amgen's Ph3 Biosimilar Stelara Trial Boasts Positive Results

Featured Editorial
Industry Insights
The Path To Commercialization For Wearable Drug Delivery Devices

Explore the evolution of the wearable drug delivery market, including the route to commercialization and the challenges faced.

Manufacturing Of Sterile Aqueous Suspensions: A Primer

Sterile suspensions are particularly difficult to manufacture. This technical article covers factors for success, including particle size, vehicle formulation, and considerations for high-shear mixing. 

Designing Successful Viral Clearance Studies

A review of studies that involve scaling down individual process steps, and, for each step, spiking virus into the specific process intermediate, performing the process step, and measuring the remaining virus.

Unexpected SEC Results: Can It Be Improved?

Sometimes your size exclusion chromatography (SEC) results don’t look like you want them to. Fix issues such as poor resolution, peak tailing, and fronting with the tips in this FAQ.

News Headlines
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.